← Celanese overview

Celanese vs Wanhua Chemical: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Celanese Corporation (CE)

Q3 2026
▲4

Celanese cuts debt, wins legal case, raises prices, adds robot demand

  • Debt reduction via Nutrinova stake sale Celanese is selling another 19% of its Nutrinova food-ingredients venture to Mitsui for about $152 million, cutting its stake to 11%. The cash goes toward paying down debt, part of a plan to raise $1 billion from asset sales by 2027. Lower debt makes the company safer and supports the stock.

    This is a major new step in Celanese's deleveraging plan, directly improving its financial health and reducing risk.

  • Legal claims dismissed in Amsterdam A Dutch court threw out all damages claims against Celanese from Shell and Repsol over past ethylene purchases. This removes a potential financial liability and simplifies the risk picture. With one less legal overhang, investors can focus on the business, which helps the stock.

    The court dismissal eliminates a significant legal risk that had been weighing on Celanese shares.

  • Price hikes on key acetyl products Celanese raised prices on four acetyl products, including acetic acid and vinyl acetate monomer, by up to $0.06 per pound in the US and Canada, with increases elsewhere. Higher prices can boost revenue and profit, especially after its Acetyl Chain sales jumped 28% in the second quarter. This supports the stock.

    The price increases show Celanese's ability to improve pricing, a direct positive for earnings and investor sentiment.

  • New demand from humanoid robot partnership Celanese teamed up with VIGOR Precision to supply high-performance plastics for humanoid robot joints, aiming to cut joint weight by over 30% versus metal. This opens a new market for Celanese's specialty materials, potentially adding future sales and showing growth beyond traditional chemicals.

    The partnership represents a new demand source and innovation, which could drive future revenue growth.

August 2026
▲4

Celanese cuts debt, wins legal case, raises prices, adds robot demand

  • Debt reduction via Nutrinova stake sale Celanese is selling another 19% of its Nutrinova food-ingredients venture to Mitsui for about $152 million, cutting its stake to 11%. The cash goes toward paying down debt, part of a plan to raise $1 billion from asset sales by 2027. Lower debt makes the company safer and supports the stock.

    This is a major new step in Celanese's deleveraging plan, directly improving its financial health and reducing risk.

  • Legal claims dismissed in Amsterdam A Dutch court threw out all damages claims against Celanese from Shell and Repsol over past ethylene purchases. This removes a potential financial liability and simplifies the risk picture. With one less legal overhang, investors can focus on the business, which helps the stock.

    The court dismissal eliminates a significant legal risk that had been weighing on Celanese shares.

  • Price hikes on key acetyl products Celanese raised prices on four acetyl products, including acetic acid and vinyl acetate monomer, by up to $0.06 per pound in the US and Canada, with increases elsewhere. Higher prices can boost revenue and profit, especially after its Acetyl Chain sales jumped 28% in the second quarter. This supports the stock.

    The price increases show Celanese's ability to improve pricing, a direct positive for earnings and investor sentiment.

  • New demand from humanoid robot partnership Celanese teamed up with VIGOR Precision to supply high-performance plastics for humanoid robot joints, aiming to cut joint weight by over 30% versus metal. This opens a new market for Celanese's specialty materials, potentially adding future sales and showing growth beyond traditional chemicals.

    The partnership represents a new demand source and innovation, which could drive future revenue growth.

Latest
▲4

Celanese cuts debt, wins legal case, raises prices, adds robot demand

  • Debt reduction via Nutrinova stake sale Celanese is selling another 19% of its Nutrinova food-ingredients venture to Mitsui for about $152 million, cutting its stake to 11%. The cash goes toward paying down debt, part of a plan to raise $1 billion from asset sales by 2027. Lower debt makes the company safer and supports the stock.

    This is a major new step in Celanese's deleveraging plan, directly improving its financial health and reducing risk.

  • Legal claims dismissed in Amsterdam A Dutch court threw out all damages claims against Celanese from Shell and Repsol over past ethylene purchases. This removes a potential financial liability and simplifies the risk picture. With one less legal overhang, investors can focus on the business, which helps the stock.

    The court dismissal eliminates a significant legal risk that had been weighing on Celanese shares.

  • Price hikes on key acetyl products Celanese raised prices on four acetyl products, including acetic acid and vinyl acetate monomer, by up to $0.06 per pound in the US and Canada, with increases elsewhere. Higher prices can boost revenue and profit, especially after its Acetyl Chain sales jumped 28% in the second quarter. This supports the stock.

    The price increases show Celanese's ability to improve pricing, a direct positive for earnings and investor sentiment.

  • New demand from humanoid robot partnership Celanese teamed up with VIGOR Precision to supply high-performance plastics for humanoid robot joints, aiming to cut joint weight by over 30% versus metal. This opens a new market for Celanese's specialty materials, potentially adding future sales and showing growth beyond traditional chemicals.

    The partnership represents a new demand source and innovation, which could drive future revenue growth.

Wanhua Chemical Group Co Ltd (600309.CG)

Q3 2026
▲3

Wanhua's profit surges on price hikes and tight MDI supply

  • Wanhua leads global MDI/TDI price hikes Wanhua and rivals Huntsman and BASF raised MDI and TDI prices by $200-300 per tonne, driven by higher costs and plant maintenance. As the world's largest MDI producer, Wanhua benefits directly from higher prices, lifting its revenue and profit.

    This is the core pricing driver behind Wanhua's earnings surge and stock appeal.

  • First-half profit jumps 64%, dividend announced Wanhua reported first-half revenue up 31% to 119.3 billion yuan and net profit up 64% to 10.06 billion yuan, with a 2.5 billion yuan dividend. Strong results confirm the upcycle and reward shareholders, supporting the stock price.

    Earnings and dividend are the clearest fundamental proof of the company's health.

  • Global MDI supply stays tight through 2028 Analysts expect a global MDI supply-demand gap of about 220,000 tonnes from 2026 to 2028, with capacity shifting to China where Wanhua has a cost advantage. Tight supply supports higher prices and margins for Wanhua.

    This structural supply gap underpins the positive long-term outlook for Wanhua's main product.

  • Maintenance shutdowns and restarts balance supply Wanhua's Yantai MDI plant shut for 45 days from August 10 and restarted by September 29, while its Fujian and Hungarian units also resumed. These routine outages temporarily tighten supply but restore volumes, keeping overall supply stable.

    Plant maintenance and restarts affect near-term supply but are routine and largely neutral for the big picture.

August 2026
▲3

Wanhua's profit surges on price hikes and tight MDI supply

  • Wanhua leads global MDI/TDI price hikes Wanhua and rivals Huntsman and BASF raised MDI and TDI prices by $200-300 per tonne, driven by higher costs and plant maintenance. As the world's largest MDI producer, Wanhua benefits directly from higher prices, lifting its revenue and profit.

    This is the core pricing driver behind Wanhua's earnings surge and stock appeal.

  • First-half profit jumps 64%, dividend announced Wanhua reported first-half revenue up 31% to 119.3 billion yuan and net profit up 64% to 10.06 billion yuan, with a 2.5 billion yuan dividend. Strong results confirm the upcycle and reward shareholders, supporting the stock price.

    Earnings and dividend are the clearest fundamental proof of the company's health.

  • Global MDI supply stays tight through 2028 Analysts expect a global MDI supply-demand gap of about 220,000 tonnes from 2026 to 2028, with capacity shifting to China where Wanhua has a cost advantage. Tight supply supports higher prices and margins for Wanhua.

    This structural supply gap underpins the positive long-term outlook for Wanhua's main product.

  • Maintenance shutdowns and restarts balance supply Wanhua's Yantai MDI plant shut for 45 days from August 10 and restarted by September 29, while its Fujian and Hungarian units also resumed. These routine outages temporarily tighten supply but restore volumes, keeping overall supply stable.

    Plant maintenance and restarts affect near-term supply but are routine and largely neutral for the big picture.

Latest
▲3

Wanhua's profit surges on price hikes and tight MDI supply

  • Wanhua leads global MDI/TDI price hikes Wanhua and rivals Huntsman and BASF raised MDI and TDI prices by $200-300 per tonne, driven by higher costs and plant maintenance. As the world's largest MDI producer, Wanhua benefits directly from higher prices, lifting its revenue and profit.

    This is the core pricing driver behind Wanhua's earnings surge and stock appeal.

  • First-half profit jumps 64%, dividend announced Wanhua reported first-half revenue up 31% to 119.3 billion yuan and net profit up 64% to 10.06 billion yuan, with a 2.5 billion yuan dividend. Strong results confirm the upcycle and reward shareholders, supporting the stock price.

    Earnings and dividend are the clearest fundamental proof of the company's health.

  • Global MDI supply stays tight through 2028 Analysts expect a global MDI supply-demand gap of about 220,000 tonnes from 2026 to 2028, with capacity shifting to China where Wanhua has a cost advantage. Tight supply supports higher prices and margins for Wanhua.

    This structural supply gap underpins the positive long-term outlook for Wanhua's main product.

  • Maintenance shutdowns and restarts balance supply Wanhua's Yantai MDI plant shut for 45 days from August 10 and restarted by September 29, while its Fujian and Hungarian units also resumed. These routine outages temporarily tighten supply but restore volumes, keeping overall supply stable.

    Plant maintenance and restarts affect near-term supply but are routine and largely neutral for the big picture.